Clinical Trials Directory

Trials / Completed

CompletedNCT03855878

Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery

Prospective Observation of the Incidence and Natural History of Monoclonal Gammopathy in Patients Undergoing Weight Reduction Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
209 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

Screening study to determine incidence of MGUS in this patient population

Detailed description

This study is designed to observe the incidence of monoclonal gammopathy of undetermined significance (MGUS) among obese patients planning to have weight reduction surgery or planning to enter into a physician monitored weight loss program and to follow the regression or progression of MGUS following surgery or the initiation of the weight loss program.

Conditions

Timeline

Start date
2018-12-10
Primary completion
2022-02-17
Completion
2024-09-12
First posted
2019-02-27
Last updated
2024-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03855878. Inclusion in this directory is not an endorsement.